Assessment of fractional flow reserve with pressure wire–based physiologic guidance of percutaneous coronary intervention (PCI) improves clinical

Multiple U.S. guidelines recommend lowering low-density lipoprotein cholesterol (LDL-C) to below 70 mg/dL in patients with high-risk atherosclerotic

After minor stroke or transient ischemic attack (TIA), secondary prevention efforts typically focus on preventing recurrent cerebrovascular events.

While COVID-19 vaccination reduces incidence, severity, and transmission of SARS-CoV-2 infection, more-detailed information is lacking regarding the

Evidence suggests that shorter courses of systemic corticosteroids are preferable for patients hospitalized with acute exacerbations of chronic

Sponsoring Organizations: Society of Critical Care Medicine (SCCM); European Society of Intensive Care Medicine (ESICM)BackgroundThis is the fourth

Previous reports of the impact of HIV infection on COVID-19's clinical course have left uncertainty about the interactions between those two conditions

The advantages of coronary artery bypass graft (CABG) over percutaneous coronary intervention (PCI) have been most apparent in patients with the

For patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (MI), 12 months of dual antiplatelet therapy (DAPT)

Standard first-line chemotherapy for advanced cholangiocarcinoma is gemcitabine and cisplatin. Recent data support the use of FOLFOX as a second-line